Eyebright Medical Technology Beijing Co Ltd
SSE:688050

Watchlist Manager
Eyebright Medical Technology Beijing Co Ltd Logo
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Watchlist
Price: 96.22 CNY -0.55%
Market Cap: 18.2B CNY
Have any thoughts about
Eyebright Medical Technology Beijing Co Ltd?
Write Note
Eyebright Medical Technology Beijing Co Ltd
/
Income Statement
/
Income from Continuing Operations

Eyebright Medical Technology Beijing Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Eyebright Medical Technology Beijing Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
Income from Continuing Operations
¥286.1m
CAGR 3-Years
44%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
Income from Continuing Operations
¥2B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
N/A
S
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Income from Continuing Operations
¥882m
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
22%
Autobio Diagnostics Co Ltd
SSE:603658
Income from Continuing Operations
¥1.3B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Winner Medical Co Ltd
SZSE:300888
Income from Continuing Operations
¥628.5m
CAGR 3-Years
-45%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
Income from Continuing Operations
¥1.7B
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
N/A
No Stocks Found

Eyebright Medical Technology Beijing Co Ltd
Glance View

Market Cap
18.2B CNY
Industry
Health Care

Nestled in the bustling heart of Beijing, Eyebright Medical Technology Co., Ltd. stands as a beacon of innovative healthcare solutions in China. Founded with the vision of transforming patient experiences and outcomes, the company has carved a niche for itself in the ophthalmic devices sector. Eyebright's story is one of relentless pursuit of excellence, where cutting-edge technology and medical expertise converge. The company has built its reputation around developing advanced medical instruments and devices tailored specifically for eye care, addressing pressing needs in ophthalmology by enhancing diagnostic and treatment capabilities. Their products, ranging from sophisticated intraocular lenses to state-of-the-art surgical equipment, are designed to not only improve precision in surgeries but also to elevate the overall efficiency and safety of ophthalmic procedures. Eyebright Medical Technology generates its revenue through a balanced ecosystem of product sales and strategic alliances. The company leverages its robust research and development arm to continually introduce new products and update existing ones, ensuring compatibility with the latest medical standards and customer demands. Collaborating with a network of hospitals, clinics, and healthcare providers, Eyebright extends its reach across China and beyond, supplying essential ophthalmic equipment to practitioners dedicated to superior eye care. Furthermore, by maintaining strong partnerships with global optical giants, they benefit from cross-border knowledge and technology exchange, which fuels their growth trajectory. This multifaceted approach not only anchors them firmly in the healthcare landscape but also positions them advantageously in the face of ever-evolving industry challenges.

Intrinsic Value
79.45 CNY
Overvaluation 17%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Eyebright Medical Technology Beijing Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
286.1m CNY

Based on the financial report for Dec 31, 2023, Eyebright Medical Technology Beijing Co Ltd's Income from Continuing Operations amounts to 286.1m CNY.

What is Eyebright Medical Technology Beijing Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
70%

Over the last year, the Income from Continuing Operations growth was 26%. The average annual Income from Continuing Operations growth rates for Eyebright Medical Technology Beijing Co Ltd have been 44% over the past three years , 70% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 215,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.